Stoke Therapeutics (STOK) Interest Coverage Ratio (2025 - 2026)
Stoke Therapeutics (STOK) recorded quarterly Interest Coverage Ratio of 2322.52 in Q1 2026, down 102.09% quarter-over-quarter from 111240.0 in Q1 2025, and down 102.09% on a YoY basis from 111240.0 in Q1 2025.
Stoke Therapeutics (STOK) Interest Coverage Ratio (2025 - 2026) Analysis & Trends
Stoke Therapeutics' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 2322.52 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.95 Bn | - | -2,322.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,322.52 |
| Mar 31, 2025 | 111,240.00 |